Cytokine networks in systemic lupus erythematosus
- PMID: 20414360
- PMCID: PMC2857803
- DOI: 10.1155/2010/676284
Cytokine networks in systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease more prominent in women and characterized by multiple organ damage. Imbalance in cytokine production and cytokine levels correlates with SLE progression, making the understanding of SLE cytokine networks very important for SLE treatment strategy and drug development. In this article, we review cytokine networks that may be involved in the pathogenesis of SLE by briefly describing abnormal cytokine production and serum cytokine levels in SLE patients. We also focus on the pathological roles of cytokines and their interactions in immunoregulatory networks and suggest how their disturbances may implicate in pathological conditions in SLE. Finally, we further discuss the influence of estrogen on these cytokine networks.
References
-
- Kotzin BL. Systemic lupus erythematosus. Cell. 1996;85(3):303–306. - PubMed
-
- Rood MJ, van der Velde EA, Ten Cate R, Breedveld FC, Huizinga TWJ. Female sex hormones at the onset of systemic lupus erythematosus affect survival. British Journal of Rheumatology. 1998;37(9):1008–1010. - PubMed
-
- Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nature Medicine. 2007;13(2):139–145. - PubMed
-
- Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. Journal of Clinical Immunology. 1993;13(1):58–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
